Invasive meningococcal disease (IMD): Your teen may be at risk

Help protect your teens and young adults from IMD with Menactra®

The flu can affect you and your loved ones every year

For helping to protect people as young as six months of age against four different strains of the flu (H1N1, H3N2, Yamagata and Victoria) contained in the vaccine.

Choose a high-dose flu shot

Specially formulated for people over 65 and offers protection against four different influenza strains (H1N1, H3N2, Yamagata and Victoria) contained in the vaccine.

The first and only quadrivalent influenza vaccine in Canada that uses a recombinant manufacturing process

The SupemtekTM vaccine, for adults 18 and older, uses recombinant vaccine technology in the manufacturing process. SupemtekTM is a quadrivalent influenza vaccine designed to help protect you against the flu.

At Sanofi Pasteur we are proud our vaccines can help protect us and our loved ones from a wide range of severe infectious diseases, at every stage of life. We supply one billion doses to people around the world each year and seek relentlessly to extend the benefits of vaccination to new infectious diseases while improving existing vaccines to enhance health and wellbeing.

FLUZONE® Quadrivalent vaccine logo

About Fluzone® Quadrivalent

FLUZONE® High-Dose Quadrivalent vaccine logo

About Fluzone® High-Dose Quadrivalent

SUPEMTEKTM vaccine logo

About Supemtek™

MENACTRA® vaccine logo

About Menactra®

Find a clinic

    Indication and safety information:

    Menactra® is a vaccine that is used to prevent meningococcal diseases and/or septicemia (blood poisoning) caused by bacteria called Neisseria meningitidis (serogroups A, C, Y and W-135). This vaccine may be given to persons 9 months through 55 years of age. Menactra® is not indicated for the prevention of invasive meningococcal disease caused by serogroup B. Menactra® is not to be used for the treatment of invasive meningococcal disease, and cannot prevent complications or death after the onset of the disease. Persons previously diagnosed with Guillain-Barré syndrome (GBS) may be at increased risk of GBS after receiving Menactra®. Persons with an allergy to any component of the vaccine or the container should not receive the vaccine. As with any vaccine, Menactra® may not protect 100% of vaccinated individuals. Adverse reactions and side effects may occur. The most common side effects in adolescents and adults (11-55 years old) were pain, induration, redness and swelling at the injection site, and headache, fatigue and malaise. Talk to your healthcare provider to see if Menactra® is right for you or a family member. For more information, visit www.sanofi.ca.

    Fluzone® Quadrivalent is a vaccine used to prevent influenza caused by the 4 strains of influenza virus (A/H1N1, A/H3N2, B/Victoria lineage, B/Yamagata lineage) contained in the vaccine. This vaccine may be given to adults and children 6 months of age and older. Persons with a history of severe allergic reaction to eggs or egg products or any component of Fluzone® Quadrivalent should not receive the vaccine. Fluzone® Quadrivalent will only protect against the strains of influenza virus contained in the vaccine or those that are closely related. It will not protect against any other strains of influenza virus. As with any vaccine, immunization with influenza vaccine may not protect 100% of individuals. Because flu viruses change over time, annual influenza vaccination is recommended for influenza. Some persons may experience side effects and allergic reactions. The most common are soreness at the site of injection and muscle pain, and infants may suffer from irritability. Most patients recover. Talk to your healthcare provider to ensure that Fluzone® Quadrivalent is right for you. For more information, visit www.sanofi.ca.

    Fluzone® High-Dose Quadrivalent is a vaccine used to prevent influenza in adults 65 years of age and older. Influenza (or flu) is an infection caused by the influenza virus. Annual vaccination using the current vaccine is recommended for prevention against influenza as immunity declines in the year following vaccination and because circulating strains of influenza virus change from year to year. Persons with a history of severe allergic reaction to eggs or egg products or any component of Fluzone® High-Dose Quadrivalent should not receive the vaccine. Fluzone® High-Dose Quadrivalent will only protect against the strains of influenza virus contained in the vaccine or those that are closely related. Fluzone® High-Dose Quadrivalent will not protect against any other strains of influenza virus. Fluzone® High-Dose Quadrivalent is not indicated for the prevention of hospitalization or death or to reduce the risk of complications after the onset of disease. As with all vaccines, Fluzone® High-Dose Quadrivalent does not protect 100% of people immunized. The most common side effects are pain at the injection site, muscle ache. Allergic reactions can occur. Contact your healthcare provider to see if this vaccine is right for you. For more information, visit www.sanofi.ca.

    SupemtekTM is a vaccine used to prevent influenza. This vaccine may be given to adults 18 years and older. Annual influenza vaccination is recommended because immunity during the year after vaccination declines and because circulating strains of influenza virus change from year to year. People who have a known severe allergy to any ingredient in SupemtekTM or who have had a severe allergic reaction after receiving a vaccine that contained similar ingredients should not use SupemtekTM . SupemtekTM will only protect against the strains of influenza virus contained in the vaccine or those that are closely related. Supemtek​​​​​​​TM will not protect against any other strains of influenza virus. Supemtek​​​​​​​TM is not indicated for the prevention of hospitalization or death or to reduce the risk of complications after the onset of disease. As with all vaccines, Supemtek​​​​​​​TM does not protect 100% of people immunized. The most common side effects are local pain and tenderness, fatigue, headache and muscle and joint pain. Talk to your doctor, nurse or pharmacist to see if this vaccine is right for you. For more information, visit www.sanofi.ca.